No abstract

The first direct ion exchange of a luminescent metal complex into an alpha-zirconium phosphate framework has been accomplished. A hydrated form of alpha-ZrP, with an expanded 10.3 A interlayer distance, has been used for the intercalation of Ru(bpy)(3)(2+), resulting in further expansion to 15.2 A. The Ru(bpy)(3)(2+) luminescence band is slightly blue-shifted. High Ru(bpy)(3)(2+) loadings lead to luminescence self-quenching.

Nitrosyl hydride, HNO or nitroxyl, is the one-electron reduced and protonated form of nitric oxide. HNO is isoelectronic to singlet O 2 , and we have previously reported that deoxy myoglobin traps free HNO to form a stable adduct. In this report, we demonstrate that oxygen-binding hemoglobins from human, soy and clam also trap HNO to form adducts which are stable over a period of weeks. The same species can be formed in higher yield by careful reduction of the ferrous nitrosyl adducts of the proteins. Like the analogous O 2 -Fe II adducts, the HNO adducts are diamagnetic, but with a characteristic HNO resonance in 1 H NMR ca. 15 ppm that splits into doublets for H 15 NO adducts. The 1 H and 15 N NMR resonances, obtained by HSQC experiments, are shown to differentiate subunits and isoforms of proteins within mixtures. An apparent difference in reduction rates of the NO-adducts of the two subunits of human hemoglobin allows assignment of two distinct nitrosyl hydride peaks by a combination of UVvis, NMR and EPR analysis. The two peaks of HNO-hHb have a persistent 3:1 ratio during trapping reactions, demonstrating a kinetic difference between HNO binding at the two subunits. These results show NMR characterization of ferrous HNO adducts as a unique tool sensitive to structural changes within the oxygen-binding cavity, which may be of use in defining modes of oxygen binding in other heme proteins and enzymes. KeywordsHNO; nitroxyl; nitrosyl hydride; dioxygen; globins; heme oxygenase Nitrosyl hydride (HNO), the protonated form of nitroxyl anion (NO − ), has distinct physicochemical properties from its congener nitric oxide (NO), much of which has been defined only recently. 1,2 The anionic form is isoelectronic with dioxygen and exists as a triplet, 3 NO − above pH 12; at lower pH the singlet 1 HNO dominates, but is susceptible to rapid † This research was supported by the National Science Foundation (PJF CHE-0100774) and the National Institutes of Health (PJF 1R21ES016441-01).*To whom correspondence should be addressed. E-mail: pfarmer@uci.edu. . SUPPORTING INFORMATION AVAILABLE. Experimental details available include descriptions of peak fitting for isoforms of native legHb mixtures, timecourse UVvis spectra during the formation of HNO-hHb, EPR characterization of ferrous NO adduct impurities in HNO adduct samples and data for initial rate analysis of HNO trapping by deoxy Mb and hHb. This material is available free of charge via the Internet at http://pubs.acs.org. NIH Public Access Author ManuscriptBiochemistry. Author manuscript; available in PMC 2010 June 9. The rate of this dimerization has been reported as 8 × 10 6 M −1 s −1,5 and thus severely limits the lifetime and concentration of HNO generated in solution.(1)HNO is the simplest analogue of alkylnitroso compounds, RNO, long known to bind to ferrous heme proteins. 6 Mansuy and coworkers were the first to describe the binding of RNO compounds to ferrous globins myoglobin (Mb) and human hemoglobin (hHb), 7 as well as to make the analogy of RNO bindi...

Doxorubicin was intercalated into novel zirconium phosphate nano-platelets (ZrP). The obtained doxorubicin intercalated ZrP nano-platelets had an impressive 34.9% (w/w) drug loading. We used this material to deliver doxorubicin to breast cancer cells (MCF-7). Cellular studies with MCF-7 cells showed higher uptake and cytotoxicity of doxorubicin loaded ZrP compared to free doxorubicin.

No abstract